The marketing of health products, with special reference to do-it-yourself tests

Medicine and Law

Volumn 22, Issue 2, 2003, Pages 199-206

  Gevers, Sjef ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Health products; Internet.; Marketing of self tests; Medical devices; Protection of public health; Right to know

Indexed keywords

DIAGNOSTIC KIT; EUROPEAN UNION; HEALTH CARE AVAILABILITY; HEALTH CARE DELIVERY; HUMAN; INTERNET; LAW; LEGAL ASPECT; MARKETING; MEDICAL INSTRUMENTATION; NETHERLANDS; PATIENT RIGHT; PHYSICAL DISEASE; POLICY; PRESCRIPTION; PRIVACY; PROTECTION; PUBLIC HEALTH; RISK FACTOR; SAFETY; SELF EVALUATION; SHORT SURVEY; WELLBEING;

EID: 0037478648     PISSN: 07231393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (8)

1. P.S. Harper, Direct marketing of cystic fibrosis carrier screening: Commercial push or population need? Jnl. Med. Genetics, 1995, 249-250.
2. S. Chandros Hull, K. Prasad, Direct-to-consumer advertising of genetic testing, Hastings Center Report 2001, May/June, 33-35.
3. W.O. Fabbri, Home HIV testing and conflicts with State HIV testing regulations, Am. Jnl. Law and Medicine 1995, 419-444.
4. See for instance, D. King, Genetic testing by post: How should it be controlled? GenEthics News, Nov./Dec. 1996, 6-7. The Nuffield Council (Mental disorders and genetics: The ethical context, London 1998) suggested that the uptake of directly marketed tests and the consequences of their use be monitored; if adverse consequences become apparent, it recommends that the government seek national of internatonal regulation of directly marketed tests.
5. Health Council of the Netherlands, DNA diagnostics, The Hague 1998, 103-104.
6. Minister of Health, Welfare and Sports, The application of genetics in the health care sector, The Hague 2001, 18 and 56.
7. Directive 98/79/EC, Off. Jnl. L 331 of 7 December 1998, 1-37.
8. See for instance S. Callens, Telemedicine and the e-commerce directive Eur. Jnl. of Health Law 2002, 93-109; Callens argues for additional safeguards, like a quality assurance system for health websites (for instance by means of a third party accreditation system) and codes of conduct on commercial communications in the medical sphere.